基因斯坦糖化物衍生物的生物合成和抗癌活性
Xing Zheng1,2, Jun Zhang1, Shun Liu2
1Department of Pharmacy, Hunan Vocational College of Science and Technology, Third Zhongyi Shan Road, Changsha, Hunan, 410004, China.
Anti-cancer agents in medicinal chemistry
|April 19, 2024
概括
基因斯坦糖化物增强了溶解性和生物可用性,克服了基因斯坦对潜在治疗用途的局限性. 本综述详细介绍了基因糖化生物合成和抗瘤结构-活性关系.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 基因斯坦是一种天然的黄类化合物,表现出多种生物活性,包括抗癌和抗氧化特性.
- 基尼斯坦的临床应用受到溶解性和生物可用性差的阻碍.
- 甘化是一种提高小分子物理化学和生物特性的策略.
研究的目的:
- 审查最近在基因斯坦糖化酶的生物合成方面的进展.
- 根据结构-活性关系,讨论基因斯坦糖化物衍生物的抗瘤活性.
- 为开发新型基因斯坦衍生物提供见解.
主要方法:
- 在PubMed/Medline和Web of Science数据库中进行文献搜索,直到2023年12月.
- 基因斯坦糖化物的合成和表征.
- 对抗瘤活性和基因斯坦糖化衍生物的结构-活性关系的评估.
主要成果:
- 基因斯坦糖化显著改善了水友性,溶解性和生物可用性.
- 基因斯坦糖化物衍生物显示出强大的抗瘤活性.
- 结构-活性关系分析揭示了增强抗癌疗效的关键修改.
结论:
- 基因斯坦糖化是一种有希望的方法,可以增强基因斯坦的治疗潜力.
- 了解基因斯坦糖化物的生物合成和结构-活性关系对于药物开发至关重要.
- 对基因斯坦衍生物的进一步研究可能会导致新的抗癌疗法.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


